Published in Cell Death Differ on May 21, 2010
The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell (2013) 2.97
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene (2011) 1.66
BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res (2011) 1.61
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene (2014) 1.23
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells. Nat Commun (2015) 1.09
SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ (2011) 1.09
SOX2 regulates YAP1 to maintain stemness and determine cell fate in the osteo-adipo lineage. Cell Rep (2013) 1.07
Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY) (2011) 1.02
Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage. Mol Cell Biol (2011) 1.00
Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol (2011) 0.96
An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation. Tissue Eng Part A (2011) 0.94
FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2. PLoS One (2015) 0.90
Partial characterization of the Sox2+ cell population in an adult murine model of digit amputation. Tissue Eng Part A (2012) 0.86
Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells. J Ocul Pharmacol Ther (2014) 0.83
Intercellular adhesion molecule-1 inhibits osteogenic differentiation of mesenchymal stem cells and impairs bio-scaffold-mediated bone regeneration in vivo. Tissue Eng Part A (2014) 0.82
The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice. Bone (2011) 0.82
Over-expression of Sox2 in C3H10T1/2 cells inhibits osteoblast differentiation through Wnt and MAPK signalling pathways. Int Orthop (2011) 0.81
Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges. Cancer Immunol Immunother (2010) 0.81
PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. Oncotarget (2016) 0.77
Low Oxygen Modulates Multiple Signaling Pathways, Increasing Self-Renewal, While Decreasing Differentiation, Senescence, and Apoptosis in Stromal MIAMI Cells. Stem Cells Dev (2016) 0.77
Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone. Bone (2012) 0.77
Sox2 is dispensable for primary melanoma and metastasis formation. Oncogene (2017) 0.76
Embryonic stem cells and inducible pluripotent stem cells: two faces of the same coin? Aging (Albany NY) (2012) 0.76
Potential role of S-adenosylmethionine in osteosarcoma development. Onco Targets Ther (2016) 0.75
Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole. PLoS One (2017) 0.75
Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation. Open Access Maced J Med Sci (2016) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell (2002) 15.20
Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev (2003) 12.38
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 11.40
SOX2 functions to maintain neural progenitor identity. Neuron (2003) 7.48
How is pluripotency determined and maintained? Development (2007) 6.92
Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev (1995) 5.42
Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci U S A (2001) 4.51
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev (2002) 4.16
SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev (2006) 4.11
Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast. Dev Dyn (2002) 4.01
The osteoblast: a sophisticated fibroblast under central surveillance. Science (2000) 3.93
Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development (2007) 3.56
Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord (2006) 3.25
Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci (2009) 2.85
Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol (2007) 2.78
Expression and activity of osteoblast-targeted Cre recombinase transgenes in murine skeletal tissues. Int J Dev Biol (2004) 2.15
Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol (2000) 2.08
Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol (2005) 2.00
Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet (1995) 1.85
Trabecular bone pattern factor--a new parameter for simple quantification of bone microarchitecture. Bone (1992) 1.53
Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol (2008) 1.46
Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc Natl Acad Sci U S A (2007) 1.46
Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res (2001) 1.35
Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp Cell Res (2007) 1.34
The effects of fibroblast growth factor-2 on human neonatal calvaria osteoblastic cells are differentiation stage specific. J Bone Miner Res (1998) 1.31
Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology (1995) 1.28
Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1-/- mice. Proc Natl Acad Sci U S A (2008) 1.22
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice. J Cell Sci (2007) 1.20
Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J Bone Miner Res (1999) 1.14
FGF and FGFR signaling in chondrodysplasias and craniosynostosis. J Cell Biochem (2005) 1.11
Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J Cell Biochem (2003) 1.06
Identification of genes differentially expressed by prematurely fused human sutures using a novel in vivo - in vitro approach. Differentiation (2007) 0.98
Fibroblast growth factor signaling uses multiple mechanisms to inhibit Wnt-induced transcription in osteoblasts. Mol Cell Biol (2008) 0.96
Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genes. J Cell Biochem (1996) 0.85
DLX5 overexpression impairs osteogenic differentiation of human bone marrow stromal cells. Eur J Cell Biol (2008) 0.83
Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta. Curr Pharm Des (2004) 0.82
Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev (1995) 5.42
An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell (1987) 3.78
Premature of chromosome condensation in a ts DNA- mutant of BHK cells. Cell (1978) 3.55
Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol (1997) 3.34
Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A (1998) 2.78
Sox2 regulatory sequences direct expression of a (beta)-geo transgene to telencephalic neural stem cells and precursors of the mouse embryo, revealing regionalization of gene expression in CNS stem cells. Development (2000) 2.73
Loss of integrated viral DNA sequences in polyomatransformed cells is associated with an active viral A function. Cell (1979) 2.61
State of the viral DNA in rat cells transformed by polyoma virus. I. Virus rescue and the presence of nonintergrated viral DNA molecules. J Virol (1976) 2.53
Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1. Science (1990) 2.40
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol (2000) 2.08
Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J Biol Chem (2000) 2.04
FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev (1999) 1.94
Mutation causing temperature-sensitive expression of cell transformation by a tumor virus (SV40-3T3 mouse cells-growth control). Proc Natl Acad Sci U S A (1972) 1.92
Radiation target size of the lytic and the transforming ability of polyoma virus. Proc Natl Acad Sci U S A (1965) 1.91
A murine fibroblast growth factor (FGF) receptor expressed in CHO cells is activated by basic FGF and Kaposi FGF. Proc Natl Acad Sci U S A (1990) 1.90
Properties and uses of human-mouse hybrid cell lines. Nature (1968) 1.82
Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J Cell Physiol (2001) 1.79
Polyoma large T antigen regulates the integration of viral DNA sequences into the genome of transformed cells. Cell (1981) 1.78
Temperature sensitive mutants of BHK cells affected in cell cycle progression. J Cell Physiol (1977) 1.76
Processing, secretion, and biological properties of a novel growth factor of the fibroblast growth factor family with oncogenic potential. Mol Cell Biol (1988) 1.69
Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas. Oncogene (2011) 1.66
Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol (2000) 1.65
Isolation of cDNAs encoding four mouse FGF family members and characterization of their expression patterns during embryogenesis. Dev Biol (1990) 1.64
Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci U S A (1997) 1.64
Infection of thymidine kinase-deficient BHK cells with polyoma virus. Nature (1966) 1.63
State of the viral DNA in rat cells transformed by polyma virus. II. Identification of the cells containing nonintegrated viral DNA and the effect of viral mutations. J Virol (1977) 1.62
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol Cell Biol (1994) 1.61
Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression. J Virol (1985) 1.60
Suppression of production of mouse 28S ribosomal RNA in mouse-human hybrids segregating mouse chromosomes. Proc Natl Acad Sci U S A (1977) 1.60
Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J Exp Med (1986) 1.60
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem (1994) 1.58
Expression and function of FGF-4 in peri-implantation development in mouse embryos. Development (1994) 1.51
A temperature-sensitive mutation affecting 28S ribosomal RNA production in mammalian cells. Proc Natl Acad Sci U S A (1973) 1.49
Analysis of a method for selecting temperature-sensitive mutants of BHK cells. Somatic Cell Genet (1978) 1.48
A temperature-sensitive cell cycle mutant of the BHK cell line. J Cell Physiol (1974) 1.47
The interaction of polyoma virus with mouse-hamster somatic hybrid cells. Virology (1970) 1.42
Origin of the thymidine kinase induced by polyoma virus in productively infected cells. J Virol (1969) 1.41
Activation of FGF receptors by mutations in the transmembrane domain. Oncogene (1997) 1.38
Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proc Natl Acad Sci U S A (1987) 1.38
Amplification of integrated viral DNA sequences in polyoma virus-transformed cells. Proc Natl Acad Sci U S A (1980) 1.38
Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene (1997) 1.38
STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development (2001) 1.36
Temperature-sensitive mutations in animal cells. Adv Cancer Res (1977) 1.36
Temperature sensitive mutants of BHK 21 cells. Nat New Biol (1972) 1.36
The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding. Mol Cell Biol (1995) 1.36
Adenovirus E1a proteins repress expression from polyomavirus early and late promoters. Mol Cell Biol (1986) 1.36
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. Proc Natl Acad Sci U S A (1992) 1.30
Molecular cloning of a gene that is necessary for G1 progression in mammalian cells. Proc Natl Acad Sci U S A (1987) 1.29
Amplification and excision of integrated polyoma DNA sequences require a functional origin of replication. Cell (1984) 1.26
Regulation of polyomavirus late promoter activity by viral early proteins. J Virol (1986) 1.26
Recommendations for airway control and difficult airway management. Minerva Anestesiol (2005) 1.24
A putative receptor tyrosine kinase with unique structural topology. Oncogene (1991) 1.24
Relationship between integrated and nonintegrated viral DNA in rat cells transformed by polyoma virus. J Virol (1980) 1.22
Regulation of asparagine synthetase gene expression by amino acid starvation. Mol Cell Biol (1991) 1.22
Cis- and trans-acting elements involved in amino acid regulation of asparagine synthetase gene expression. Mol Cell Biol (1993) 1.22
Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol (1999) 1.21
Integration and excision of polyoma virus genomes. Cold Spring Harb Symp Quant Biol (1980) 1.21
Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol (1998) 1.20
Regulation of viral transciption and tumor antigen expression in cells transformed by simian virus 40. Proc Natl Acad Sci U S A (1976) 1.17
Requirement for the integrity of the viral genome for the induction of host DNA synthesis by polyoma virus. Proc Natl Acad Sci U S A (1966) 1.16
Transcription from the polyoma late promoter in cells stably transformed by chimeric plasmids. Mol Cell Biol (1985) 1.16
Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol (1997) 1.15
Presence of chromosomal abnormalities and lack of AIDS retrovirus DNA sequences in AIDS-associated Kaposi's sarcoma. Cancer Res (1986) 1.14
DNA sequence requirements for replication of polyomavirus DNA in vivo and in vitro. Mol Cell Biol (1987) 1.14
Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J (1992) 1.14
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists. Oncogene (1999) 1.14
Common regulatory elements control gene expression from polyoma early and late promoters in cells transformed by chimeric plasmids. Mol Cell Biol (1985) 1.12
Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Cancer Res (2000) 1.11
Organization and expression of the cell cycle gene, ts11, that encodes asparagine synthetase. Mol Cell Biol (1989) 1.11
Molecular cloning, germ-line transformation, and transcriptional analysis of the zeste locus of Drosophila melanogaster. Proc Natl Acad Sci U S A (1986) 1.10
Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J Cell Physiol (1997) 1.09
Susceptibility to superinfection of hybrids between polyoma "transformed" BHK and "normal" 3T3 cells. Nat New Biol (1971) 1.07
Changes in the topography of early region transcription during polyoma virus lytic infection. Proc Natl Acad Sci U S A (1982) 1.07
Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc Natl Acad Sci U S A (1998) 1.07
Transformation by basic fibroblast growth factor requires high levels of expression: comparison with transformation by hst/K-fgf. Oncogene Res (1989) 1.05
Cleavage and release of a soluble form of the receptor tyrosine kinase ARK in vitro and in vivo. J Cell Physiol (1996) 1.05
Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor. J Neurosci (1996) 1.05
Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors. Mol Cell Biol (1994) 1.04
Isolation of the human gene that complements a temperature-sensitive cell cycle mutation in BHK cells. Mol Cell Biol (1987) 1.04
Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells. Mol Cell Biol (1990) 1.03
Requirements for excision and amplification of integrated viral DNA molecules in polyoma virus-transformed cells. J Virol (1982) 1.03
Role of fibroblast growth factor receptor signaling in prostate cancer cell survival. J Natl Cancer Inst (2001) 1.03
Mutant of polyoma virus with impaired adsorption to BHK cells. J Virol (1974) 1.02
Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis. Mol Cell Biol (2001) 1.02
A mammalian temperature-sensitive mutation affecting G1 progression results from a single amino acid substitution in asparagine synthetase. Nucleic Acids Res (1990) 1.01
Polio vaccine samples not linked to AIDS. Nature (2001) 1.01
Surface changes in temperature-sensitive Simian virus 40-transformed cells. Proc Natl Acad Sci U S A (1973) 1.01
Different point mutations in the met oncogene elicit distinct biological properties. FASEB J (2000) 1.01
Human fibroblasts transformed by the early region of SV40 DNA: analysis of "free" viral DNA sequences. Virology (1980) 1.00
Synthesis of H1 histones by BHK cells in G1. Cell (1978) 1.00